Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19-United States, April-September 2022

Shah, MM; Joyce, B; Plumb, ID; Sahakian, S; Feldstein, LR; Barkley, E; Paccione, M; Deckert, J; Sandmann, D; Gerhart, JL; Hagen, MB

Shah, MM (通讯作者),CDC, Coronavirus & Other Resp Viruses Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30322 USA.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022; 71 (48): 1531

Abstract

What is already known about this topic? Nirmatrelvir-ritonavir (Paxlovid) is an outpatient antiviral medication recommended for adults with mild-to-mo......

Full Text Link